synbio新材料
Search documents
微构工场ⅹ安琪酵母,全国首条万吨级合成生物PHA生产线竣工交付!
synbio新材料· 2025-05-13 07:23
扫码进 生物基新材料群 备注:姓名+公司+职位 资料来源: 声明: 因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文由作者重新编写,仅作新材料相关领域介绍,本文 不构成任何投资建议!转载请注明来源! 据中国化学消息,近日,由中国化学十六化建承建的微琪生物年产 3万吨合成生物PHA可降解材料项目 (一期) 通过竣工验收,标志着全国首条万吨级PHA生产线正式交付。 据悉,微琪生物是由 微构工场 与 安琪酵母 分别按照60%和40%的出资比例设立,已于2022年9月 29日完成工商注册登记,注册资本1亿元。 微琪生物3万吨PHA生物可降解材料项目是 国内拟建产能中规模最大的PHA产线 ,也是中国首条万吨 级PHA生产线 。 该项目占地约200亩,总投资10.5亿元,2023年6月正式动工,分两期建设。此次竣工的 一期 项目 总投资 2.5 亿元。 一期1万吨达产达效后,每年可实现销售额3.7亿元、税收3400万元左右。 项目采用 最前沿的生物发酵技术和先进的智能制造系统 ,规划建设集全流程自动化生产线、综合集成 信息管控平台、实时协同优化的智能生产体系、精细化能效管控于一体的绿色、安全、高效的智能工 ...
新皮革材料?利用合成生物学技术重现恐龙皮!即将进入奢侈品市场
synbio新材料· 2025-05-09 06:49
声明: 因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作新材料相关领域介绍,本文不构成任何投资建议!转载请注明来源! 一直以来,奢侈品都被广泛认为是身份和地位的象征,支撑其价值观的一大重要因素就是"独家稀缺性"。这不仅体现在产量的稀少上,独特的材质也是打 造稀缺性的重要构成,例如爱马仕的稀有鳄鱼皮包喜马拉雅系列最高售价可超过200万元。 寻找更小众稀有的材质并将其商业化一直是奢侈品品牌的工作,在皮革上的表现包括但不限于食蚁兽皮,甚至是已灭绝动物的 生物合成皮革。 而一种新的皮革可能即将进入市场,科学家打算在今年年底前利用 全球首款通过 合成生物学技术 复刻的恐龙皮 制作手提包、钱包和皮带。 霸王龙皮包的模型 打造恐龙皮革包包 这款皮革的技术由组织工程材料公司BSF Enterprise PLC的子公司Lab-Grown Leather Ltd.开发,该公司在4月25日与创意机构VML(WPP PLC 旗下集团 公司)、基因组工程领导者The Organoid Company宣布合作,共同将利用已灭绝霸王龙的 DNA 打造的全球首款皮革推向市场。 该公司表示,初期应用将专注于配饰,目标是在2 ...
【免费参会】第三届中国合成生物学“科学家+企业家+投资家”大会!邀您8月共聚苏州!
synbio新材料· 2025-05-09 06:49
Group 1 - The article highlights the growing attention and support for synthetic biology, biomanufacturing, and the bio-industry from various sectors including government, academia, and investment, with many local governments incorporating synthetic biological manufacturing into their work reports [1] - The upcoming third SynBio Suzhou conference will take place on August 1-2, 2025, at the Suzhou International Expo Center, covering topics such as agriculture, food, energy, medical aesthetics, pharmaceuticals, and health [3] - The seventh CMC-China Expo is expected to attract 20,000 attendees, featuring 450 exhibiting companies and 600 invited guests, with multiple forums and a dedicated synthetic biology exhibition area [16] Group 2 - The article lists notable past guests and speakers from various institutions and companies, indicating a diverse representation of expertise in the field of synthetic biology [4][7][9] - The event aims to gather scientists, entrepreneurs, and investors to collaborate and discuss the future of synthetic biology and its applications [2][3] - The article emphasizes the importance of industry collaboration and innovation in advancing synthetic biology and biomanufacturing [1][26]
金发科技:特种工程塑料业务增长强劲;已成立人形机器人材料研发团队
synbio新材料· 2025-05-09 06:26
Core Viewpoint - The company, Jinfat Technology, reported significant growth in both revenue and net profit for 2024 and Q1 2025, indicating strong operational performance and cash flow generation [1]. Group 1: Financial Performance - In 2024, Jinfat Technology achieved operating revenue of 60.514 billion yuan, a year-on-year increase of 26.23%, and a net profit attributable to shareholders of 0.825 billion yuan, up 160.36% [1]. - For Q1 2025, the company reported operating revenue of 15.666 billion yuan, reflecting a 49.06% year-on-year growth, with a net profit of 0.247 billion yuan, an increase of 138.20% [1]. - The net cash flow from operating activities reached 2.845 billion yuan in 2024, marking an 18.24% increase compared to the previous year [1]. Group 2: Special Engineering Plastics Business - In Q1 2025, the special engineering plastics segment maintained strong growth, achieving sales of 0.63 million tons, a 91% increase year-on-year [2]. - The company has invested in downstream application development and is actively advancing capacity construction, with a 6,000-ton PPSU facility launched in June 2024 and a 15,000-ton LCP facility expected to start production in Q2 2025 [2]. - Jinfat Technology is developing new products such as long-chain polyamide, transparent polyamide, polyamide elastomer, high-heat transparent polyester, ultra-high heat LCP, and thermoplastic polyimide [2]. - The special engineering plastics are primarily used in consumer electronics, automotive, and new energy sectors, with applications also emerging in humanoid robotics [2]. Group 3: Humanoid Robot Materials Development - The company has established a research and development team focused on materials for humanoid robots, leveraging its technical expertise from the automotive industry [3]. - Collaborations with downstream clients for material development have begun, with some clients already receiving bulk material supplies [3]. - Although the immediate contribution of the humanoid robotics sector to the company's performance is limited, it is expected to become a significant downstream application area in the long term [3]. - PEEK materials, known for their excellent mechanical properties and wear resistance, are suitable for applications in robot joints and bearings, although the market potential for PEEK in robotics is currently difficult to estimate [3].
【免费参会】第三届中国合成生物学“科学家+企业家+投资家”大会!邀您8月共聚苏州!
synbio新材料· 2025-05-09 06:26
Group 1 - The article highlights the growing attention and support for synthetic biology, biomanufacturing, and the bio-industry from various sectors including government, academia, and investment, with many local governments incorporating synthetic biological manufacturing into their work reports [1] - The upcoming third SynBio Suzhou conference will take place on August 1-2, 2025, at the Suzhou International Expo Center, covering topics such as agriculture, food, energy, medical aesthetics, pharmaceuticals, and health [3] - The seventh CMC-China Expo is expected to attract 20,000 attendees, featuring 450 exhibiting companies and 600 invited guests, with multiple forums and a dedicated synthetic biology exhibition area [16] Group 2 - The article lists notable past guests from various institutions and companies, indicating a diverse representation of expertise in the field of synthetic biology and biomanufacturing [4][7][9] - The conference aims to gather scientists, entrepreneurs, and investors to collaborate and discuss the future of synthetic biology, emphasizing the importance of industry collaboration [2][3] - The article encourages participation in the conference by offering free registration for attendees, highlighting the event's accessibility to a broader audience [13][14]
【免费参会】第三届中国合成生物学“科学家+企业家+投资家”大会!邀您8月共聚苏州!
synbio新材料· 2025-05-09 05:18
融行业智慧、共襄盛举 聚产业力量、擘画未来 第三届SynBio Suzhou中国合成生物学"科学家+企业家+投资家"大会 将于2025年8月1-2日在 苏州 国际博览中心 举办(同期举办 第七届CMC-China博览会 )! 扫码!锁定免费参会名额! 话题将覆盖: 农业、食品与能源, 医美、医药、大健康 , 合成生物技术、中试放大与商业化, 以 及 项目路演 等多个方面,诚邀莅临,共襄盛举! 往期精彩: 作为新质生产力的代表,合成生物学、生物制造以及生物产业,近些年,受到来自政产学研用金各 方广泛关注和重点支持,多地政府将合成生物制造产业写进工作报告。 科学家、企业家和投资家, 在产业发展中发挥着重要作用。 常珊 江苏理工学院 生物信息与医药工程 研究所所长 大会主办丨 Synbio深波 会议时间 | 2025年8月1-2日 会议地点 | 中国·苏州·国际博览中心B馆 扫码!锁定免费参会名额! 圆满落幕!下一站去哪?2023中国(苏州)合成生物学创新峰会成功 举办 2023中国(苏州)合成生物学产业技术峰会圆满落幕 合成生物,聚势苏州:2024中国合成生物学"科学家+企业家+投资 家"大会圆满召开! 往期嘉宾 ...
今年8月建设完成!总投资8.82亿,年产7.5万吨聚乳酸生物降解新材料项目
synbio新材料· 2025-05-09 05:18
Core Viewpoint - JinDan Technology (300829) is actively developing a 75,000-ton polylactic acid biodegradable material project, expected to be completed by August 2025, with a total investment of approximately 882 million yuan, aiming to meet the growing market demand for polylactic acid products and enhance profit growth opportunities [1]. Financial Performance - In Q1 2025, JinDan Technology reported operating revenue of 344.02 million yuan, a decrease of 1.73% year-on-year; however, net profit attributable to shareholders increased by 125.85% to 38.61 million yuan, and the net profit excluding non-recurring items surged by 216.9% to 32.96 million yuan [2][3]. - The significant increase in net profit in Q1 2025 was primarily due to stable sales of lactic acid products and a decrease in corn prices, which positively impacted overall profit levels [4]. - For the year 2024, JinDan Technology achieved total operating revenue of 1.505 billion yuan, a year-on-year increase of 6.15%, but net profit attributable to shareholders decreased by 56.01% to 37.49 million yuan [4].
万华化学签约!生物新材料等生物制造领域
synbio新材料· 2025-05-09 05:18
Core Viewpoint - The collaboration between Bio Island Laboratory and Wanhua Chemical aims to innovate in the field of bio-based materials, positioning both entities as leaders in the industry [1][2]. Group 1: Collaboration and Innovation - Bio Island Laboratory and Wanhua Chemical signed an agreement to establish the "Bio Island Laboratory-Wanhua Chemical Bio-Chemical Research and Manufacturing Innovation Consortium" [1]. - The partnership focuses on continuous innovation in bio-based materials and aims to lead the direction of industry development [1][2]. - The collaboration is part of a broader initiative to create a "government-industry-university-research-finance-application" ecosystem to accelerate the transformation of scientific achievements into productive forces [2]. Group 2: Industry Insights - The bio-manufacturing industry is projected to reach a value of approximately $30 trillion, making it a strategic area of competition among countries [2]. - Guangzhou's government is committed to supporting the transformation of scientific achievements and fostering innovation in the bio-economy, aiming to secure a strategic position in the future of this sector [2]. Group 3: Related Developments - The National Development and Reform Commission has included multiple projects related to bio-based materials and biofuels [5]. - Companies like Lianlong are leveraging synthetic biology to develop high-performance materials, indicating a trend towards innovation in polymer materials [5]. - A startup in synthetic biology has raised $6.7 million in seed funding to advance applications in protein fibers, showcasing the growing interest and investment in this field [5].
发改委发布!多个生物基材料、生物燃料等项目入选!
synbio新材料· 2025-05-08 05:48
Core Viewpoint - The article discusses the release of the second batch of the "Green Low-Carbon Advanced Technology Demonstration Project List" by the National Development and Reform Commission, which includes 101 projects aimed at carbon reduction across three main areas: source reduction, process reduction, and end-of-pipe carbon capture [1] Group 1: Biobased Materials and Fuels - The article highlights a project for producing 110,000 tons of biodegradable polyester rubber, which aims to address the degradation issues of traditional synthetic rubber, achieving a carbon reduction rate exceeding 31% [2] - Another project focuses on producing 30,000 tons of high-performance environmentally friendly biobased materials, which will reduce carbon emissions by over 30,000 tons annually [5] - A significant project involves processing 1 million tons of waste oil to produce sustainable aviation fuel, with the capacity to generate 670,000 tons of sustainable aviation fuel annually [6] - A project for producing 500,000 tons of biodiesel and sustainable aviation fuel is also mentioned, with a production capacity of 400,000 tons of various bio-liquid fuels, achieving a 75% yield for sustainable aviation fuel [8]
合成生物学布局!高分子材料抗老化龙头「利安隆」的第三生命曲线
synbio新材料· 2025-05-08 05:48
Core Viewpoint - Tianjin Lianlong New Materials Co., Ltd. is a leading company in the polymer materials anti-aging industry, expanding its business beyond polymer additives into three main business lines: polymer materials anti-aging, lubricant additives, and life sciences [2][3]. Business Development - The company has established three business curves: the first curve focuses on polymer materials anti-aging, the second on lubricant additives, and the third on life sciences [2]. - The life sciences business began in 2021 through a partnership with Jima Gene to form Aorife Biopharmaceutical Co., Ltd., focusing on the research, production, and sales of nucleic acid drugs [3]. Research and Collaboration - Lianlong has formed a synthetic biology research institute, led by Chief Scientist Sun Chunguang, with a team from prestigious universities such as Tianjin University and Dalian University of Technology [5][7]. - The company has established partnerships with top universities and research institutes to support early-stage research projects in fine chemical industry [7]. Future Prospects - With ongoing projects and advancements in research, Lianlong is expected to secure a significant position in the synthetic biology field [8].